Ligand Pharmaceuticals Enters into Research and Development Agreement with Janssen Research & Development

Ligand Pharmaceuticals Incorporated

Represented Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) in connection with a Research and Development Agreement with Janssen Research & Development, LLC for the development by Ligand of a heavy-chain-only transgenic chicken platform.

Ligand is a biopharmaceutical company that focuses on developing and/or acquiring technologies that help pharmaceutical companies in discovering and creating medicines. Janssen Research and Development is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.